NPLATE 125 micrograms, powder for solution for injection bottle
Active ingredients: Romiplostim
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injectionbottlesous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NPLATE 125 microgrammes, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- AMGEN EUROPE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Jul 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66384249CIP73013087CIP133400930130872Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ROMIPLOSTIMpoudre | 125 microgrammes · 0,25 mL de solution reconstituée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.